Results 171 to 180 of about 451,267 (297)

Access to essential medicines for noncommunicable diseases during conflicts: The case cardiovascular diseases, diabetes and epilepsy in Northern Syria. [PDF]

PLOS Glob Public Health
Aljadeeah S, Tarrafeta B, Fahed S, Kielmann K, Ravinetto R.   +4 more
europepmc   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

Equitable access to essential medicines to treat neglected tropical diseases: Latest developments from the World Health Organization (WHO). [PDF]

PLoS Negl Trop Dis
Fattah F, Lester R, Kalua K, Sharp B, Wasan KM.   +4 more
europepmc   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

“Health supply chain personnel: an integral part of the health workforce.”

Journal of Pharmaceutical Policy and Practice, 2014
Giorgio Cometto, Zaheer-Ud-Din Babar, Andrew Brown, Lisa Hedman, James Campbell   +4 more
doaj   +1 more source

Economic assessment of potential changes to essential medicines for diabetes in Uganda. [PDF]

PLoS One
Bonyani A, Lin TK, Jakira A, Kimera ID, Muddu M, Schwartz JI, Kahn JG.   +6 more
europepmc   +1 more source

(The Lancet)red: a missed opportunity. [PDF]

, 2006
Alexandra Calmy, Donnelly, Felipe Garcia de la Vega, Fernando Pascual, Gilks, Marseille, Nathan Ford, Sheila Shettle, Williams   +8 more
core   +2 more sources

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

Molecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek, Jenny Sprooten, Abhishek D. Garg   +2 more
wiley   +1 more source

A comparison of the labeling of antineoplastic and supportive medicines in China, Japan, and the US based on the WHO essential medicines list. [PDF]

Front Med (Lausanne)
Du C, Liu J, Wang C, Liu P.
europepmc   +1 more source

Essentials of Medicine [PDF]

Postgraduate Medical Journal, 1994
openaire   +1 more source